Similarly, the tumour suppressive activity of maspin has been demonstrated for prostate cancer (Umekita et al, 1997), oral carcinoma (Xia et al, 2000), and colon cancer (Song et al, 2002). This evidence concerns the gene SERPINB5 and prostate cancer.